209 related articles for article (PubMed ID: 19139835)
1. Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.
Haley ES; Au GG; Carlton BR; Barry RD; Shafren DR
J Mol Med (Berl); 2009 Apr; 87(4):385-99. PubMed ID: 19139835
[TBL] [Abstract][Full Text] [Related]
2. Potent oncolytic activity of human enteroviruses against human prostate cancer.
Berry LJ; Au GG; Barry RD; Shafren DR
Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
[TBL] [Abstract][Full Text] [Related]
3. Oncolysis of human ovarian cancers by echovirus type 1.
Shafren DR; Sylvester D; Johansson ES; Campbell IG; Barry RD
Int J Cancer; 2005 Jun; 115(2):320-8. PubMed ID: 15688406
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model.
Kawaguchi K; Etoh T; Suzuki K; Mitui MT; Nishizono A; Shiraishi N; Kitano S
Int J Oncol; 2010 Dec; 37(6):1433-8. PubMed ID: 21042711
[TBL] [Abstract][Full Text] [Related]
5. Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer.
Zhou W; Dai S; Zhu H; Song Z; Cai Y; Lee JB; Li Z; Hu X; Fang B; He C; Huang X
Gene Ther; 2017 Apr; 24(4):199-207. PubMed ID: 28075429
[TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.
Song KY; Wong J; Gonzalez L; Sheng G; Zamarin D; Fong Y
J Mol Med (Berl); 2010 Jun; 88(6):589-96. PubMed ID: 20393691
[TBL] [Abstract][Full Text] [Related]
7. Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions.
Kosaka T; Davydova J; Ono HA; Akiyama H; Hirai S; Ohno S; Takeshita F; Aoki K; Ochiya T; Yamamoto M; Kunisaki C; Endo I
Anticancer Res; 2015 Oct; 35(10):5201-10. PubMed ID: 26408678
[TBL] [Abstract][Full Text] [Related]
8. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice.
Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H
Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M
Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088
[TBL] [Abstract][Full Text] [Related]
12. Combination of the tumor angiogenesis inhibitor bevacizumab and intratumoral oncolytic herpes virus injections as a treatment strategy for human gastric cancers.
Deguchi T; Shikano T; Kasuya H; Nawa A; Fujiwara S; Takeda S; Gewen T; Sahin TT; Yamada S; Kanzaki A; Yamamura K; Fujii T; Sugimoto H; Nomoto S; Fukuda S; Nishikawa Y; Kodera Y; Nakao A
Hepatogastroenterology; 2012 Sep; 59(118):1844-50. PubMed ID: 22172413
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y
Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946
[TBL] [Abstract][Full Text] [Related]
14. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
15. Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.
Wang W; Ji W; Hu H; Ma J; Li X; Mei W; Xu Y; Hu H; Yan Y; Song Q; Li Z; Su C
Oncotarget; 2014 Jan; 5(1):150-60. PubMed ID: 24473833
[TBL] [Abstract][Full Text] [Related]
16. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
[TBL] [Abstract][Full Text] [Related]
17. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using ets-1 transcription factor decoy for peritoneal dissemination of gastric cancer.
Taniguchi H; Fujiwara Y; Doki Y; Sugita Y; Sohma I; Miyata H; Takiguchi S; Yasuda T; Tomita N; Morishita R; Monden M
Int J Cancer; 2007 Oct; 121(7):1609-17. PubMed ID: 17546598
[TBL] [Abstract][Full Text] [Related]
20. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
